Home / Spain / Oryzon Genomics, S.A.
Oryzon Genomics, S.A.
Short position disclosed on July 3, 2026.
0.63% of the capital sold short
1 disclosing funds
9 disclosures on record
ES0167733015 ISIN code
Funds holding Oryzon Genomics, S.A. Titelia
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Oct 2025Jan 2026Apr 2026Jul 2026
April 1, 2025 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Voleon Capital Management LP | 0.63% | new | July 3, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 3, 2026 | Voleon Capital Management LP | 0.63% | still open |
| May 18, 2026 | Qube Research & Technologies Ltd | 0.00% | still open |
| April 28, 2026 | Qube Research & Technologies Ltd | 0.90% | still open |
| March 27, 2026 | Qube Research & Technologies Ltd | 0.80% | still open |
| March 11, 2026 | Qube Research & Technologies Ltd | 0.72% | still open |
| March 3, 2026 | Qube Research & Technologies Ltd | 0.63% | still open |
| March 2, 2026 | Qube Research & Technologies Ltd | 0.55% | still open |
| April 2, 2025 | Citadel Securities GCS (Ireland) Limited | 0.37% | still open |
| April 1, 2025 | Citadel Securities GCS (Ireland) Limited | 0.58% | still open |
Other companies sold short in Spain
- Solaria Energia y Medioambiente, S.A. 5.55% of the capital sold short
- Edreams Odigeo, S.A. 5.43% of the capital sold short
- Enagas, S.A. 4.83% of the capital sold short
- Indra Sistemas, S.A. 2.78% of the capital sold short
- Amper, S.A. 2.60% of the capital sold short
- Tecnicas Reunidas, S.A. 2.53% of the capital sold short
- Viscofan, S.A. 2.38% of the capital sold short
- Grifols, S.A. 1.79% of the capital sold short
- Tubacex, S.A. 1.71% of the capital sold short
- Nyesa Valores Corporacion, S.A. 1.56% of the capital sold short
- Laboratorios Farmaceuticos Rovi, S.A. 1.51% of the capital sold short
- Ence Energia y Celulosa, S.A. 1.48% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Oryzon Genomics, S.A., source CNMV, data as at July 3, 2026, https://www.quivad.com/action/oryzon-genomics-s-a